Pragmatic Trials and Improving Long-Term Care: Recommendations From a National Institutes of Health Conference

Sheryl Zimmerman, Barbara Resnick, Joseph Ouslander, Cari Levy, Joseph E. Gaugler, Philip D. Sloane, Vincent Mor

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)688-694
Number of pages7
JournalJournal of the American Geriatrics Society
Issue number3
StatePublished - Mar 2022

Bibliographical note

Funding Information:
The authors thank the following conference presenters for their insights that are reflected in these recommendations: Kathleen Abrahamson (Purdue University), Nicole Brandt (University of Maryland), Cathleen Colón-Emeric (Duke University), Elizabeth Galik (University of Maryland), David Gifford (American Health Care Association), Stefan Gravenstein (Brown University), Sherry Greenberg (Gerontological Advanced Practice Nurses Association), Laura Hanson (University of North Carolina), Juliet Holt Klinger (Brookdale Senior Living), Cathy Lieblich (Pioneer Network), Sunny Linnebur (American Geriatrics Society), Angie McAllister (Signature HealthCARE), Lona Mody (University of Michigan and VA Ann Arbor Healthcare System), Arif Nazir (Society for Post-Acute and Long-Term Care Medicine), Douglas Pace (Alzheimer's Association), Robyn Stone (LeadingAge), Kathleen Unroe (Indiana University), and Hilde Verbeek (Maastricht University). This article was published in Journal of the American Medical Directors Association (JAMDA), Vol 23 Iss 3, Zimmerman et al, Pragmatic Trials and Improving Long-term Care: Recommendations from a National Institutes of Health Conference, 323-327. Copyright Elsevier on behalf of AMDA – The Society for Post-Acute and Long-Term Care Medicine, 2022.

Funding Information:
This work was supported by the National Institute on Aging (NIA), of the National Institutes of Health, United States under award number R13AG067681. S.Z., J.E.G., and V.M. were also supported by the NIA under award number U54AG063546, which funds the NIA Imbedded Pragmatic Alzheimer's Disease and AD‐Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Cite this